Standard BioTools
LAB
LAB
86 hedge funds and large institutions have $116M invested in Standard BioTools in 2023 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 27 increasing their positions, 17 reducing their positions, and 9 closing their positions.
Holders
86
Holders Change
+14
Holders Change %
+19.44%
% of All Funds
1.26%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
24
Increased
27
Reduced
17
Closed
9
Calls
$30K
Puts
$1K
Net Calls
+$29K
Net Calls Change
+$45K
Top Buyers
1 |
1
Morgan Stanley
New York
|
$17.4M |
2 |
2
Millennium Management
New York
|
$3.27M |
3 |
3
Renaissance Technologies
New York
|
$2.3M |
4 |
LCM
4
Laurion Capital Management
New York
|
$663K |
5 |
5
Jane Street
New York
|
$698K |